T -independent type 2 (TI-2) 4 Ags are large polysaccharides found in the capsules of such bacteria as Streptococcus pneumoniae, Haemophilus influenzae, and Klebsiella pneumoniae. These capsular polysaccharides do not activate the lectin or alternate pathways of complement; hence, activation of the classical pathway by Abs is required for effective opsonization (1) . Humans with impaired ability to mount Ab responses to polysaccharides, including young children and splenectomized adults, are at increased risk of life-threatening infections from encapsulated bacteria (2) .
To study Ab responses to polysaccharides, we took advantage of the quasimonoclonal (QM) mice. In the QM mice, 80% of the peripheral B cells express a BCR encoded by a knock-in VH17.2.25 H chain and the 1 or 2 L chain (3) . These mice mount enhanced responses to 4-hydroxy-3-nitrophenylacetate (NP)-Ficoll (a TI-2 Ag), owing to an increased B cell precursor frequency with a marginal zone phenotype (IgM ϩ , IgD Ϫ , and CD21 ϩ ) (4) . The marginal zone B cells are thought to constitute the first line of response to encapsulated microbes (5) .
What special properties of B cells besides the BCR may allow TI-2 responses to occur is not known. We explored the functions of the trans-membrane activator calcium modulator and cyclophylin ligand interactor (TACI), found previously to be needed to mount effective TI-2 Ab responses (6) . TACI has two known ligands: B lymphocyte stimulator (BLyS); and a proliferation inducing ligand (APRIL). Administration of BLyS to mice increased B cell numbers and enhanced Ab responses to both T-dependent Ags and TI-2 Ags (7). Conversely, mice that lack BLyS had severely reduced B cell numbers and reduced Ab responses (8) . In contrast, APRIL knockout (KO) mice have normal TI-2 responses (9), but transgenic expression of APRIL led to increased TI-2 Ab responses (10) .
BLyS and APRIL bind to two other receptors B cell activating factor receptor (BAFF-R) and B cell maturation Ag (BCMA) in addition to TACI. BCMA promoted plasma cell survival in Tdependent responses (11) but was dispensable for TI-2 Ab responses (12) ; mutations in the intracellular domain of BAFF-R (A/WySnJ mice) caused reduced Ab responses to both TI-2 Ags and T-dependent Ags and decreased numbers of peripheral B cells (13) . Thus, contribution of TACI for TI-2 Ab responses in response to BLyS and APRIL remains unclear. Previous work by the authors revealed that TACI binds uniquely to heparan sulfate posttranslational modifications of syndecan-2 (14) . Thus, some of the unique functions of TACI may be attributed to binding of TACI to heparan sulfate on syndecan 2.
Mice lacking TACI are unable to mount effective TI-2 Ab responses (6) , suggesting that TACI is needed for the generation of these responses. How TACI promotes these responses is not known. TACI-KO mice have increased numbers of all B cell subtypes (6), including marginal zone B cells (15) and B1 B cells (16) , suggesting that TACI deficiency does not impair the development of polysaccharide-responsive B cells. This contrasts with models with defective TI-2 Ab responses, owing to decreased or absent B cells in the marginal zone of the spleen or in the serosal cavities (B1 B cells). In contrast to the apparent impact on TI-2 responses, TACI is thought to inhibit some B cell functions. Thus, TACI Ϫ/Ϫ B cells hyperproliferate in response to polyclonal activators in vitro, and loss of TACI causes autoimmunity in mice (6, 17, 18) , suggesting that TACI is a B cell-inhibitory receptor. How TACI combines inhibitory and stimulatory B cell functions is not understood. Here we asked whether TACI regulates B cell differentiation after T-independent stimulation of B cells.
To determine the mechanism by which TACI controls TI-2 Ab responses, we bred TACI-KO mice with the QM mouse (3) to obtain TACI Ϫ QM mice. Because in QM mice the transgenic H chain was targeted into the JH locus, it can undergo isotype switching and somatic hypermutation. We studied how TACI promotes QM B cell responses to NP-Ficoll (a TI-2 Ag). We found that QM B cells lacking TACI are normally activated by Ag but proliferate longer and have impaired plasma cell differentiation. Our findings suggest that TACI acts remotely from B cell activation and provides a critical signal for cells to exit the cell cycle and to differentiate into plasma cells.
Materials and Methods

Mice and immunizations
TACI-KO and QM mice were previously described (3, 6) . TACI-KO mice were bred to QM mice and are in a C57BL/6 (B6) background. Animals were bred and treated according to the policies of Mayo Foundation Institutional Animal Care and Use Committee. Mice were immunized with 30 g i.p. of NP-Ficoll (NP41-AECM-Ficoll; Biosearch Technologies) diluted in sterile PBS.
Isolation of primary B cells
CD19
ϩ splenocytes were isolated by negative selection with a B cell isolation kit (Miltenyi Biotec), per the manufacturer's protocol. Cells were grown in RPMI 1640, 10% FCS, 1% v/v Pen-Strep, and 55 M 2-ME.
ELISA
NP-specific Abs in the sera were determined using ELISA, as previously described (19) . 
ELISPOT
Multiscreen HTS-HA 96-well plates purchased from Millipore were coated with 5 g/ml NP-BSA or 5 g/ml BSA in sodium carbonate buffer overnight at 4°C. Plates were blocked with 5% milk in TBS-Tween, and B cells obtained by negative selection with magnetic Miltenyi microbeads (MACS) were serially diluted from a maximum of 2 ϫ 10 5 or 5 ϫ 10 5 cells per well and cultured overnight. ELISPOTS from splenocytes isolated from adoptively transferred mice were not further processed because recipient mice lack T cells and were transferred with isolated B cells. Ab-secreting cells (ASCs) were detected with AP-conjugated goat anti-mouse IgM or IgG Ab (Southern Biotechologies) for 2 h at 37°C.
The plates were developed with 5-bromo-4-chloro-3-indolyl phosphate-NBT substrate (SigmaFast; Sigma-Aldrich), and dots were counted by microscopy.
Thymidine incorporation
Splenocytes or negatively selected B cells isolated using a MACS B cell isolation kit (Milteny Biotec) were plated at concentration 1 ϫ lysed by hypotonic lysis, transferred to glass fiber filters (Packard), and counted on a Matrix 96-Direct Beta Counter (Packard).
Adoptive transfer
Ten million negatively selected B cells isolated with the B cell isolation kit (Miltenyi Biotec) were injected into the jugular vein of RAG1 Ϫ/Ϫ mice on a B6 background 1 h before immunization.
FACS staining
Biotinylated anti-idiotypic Ab (R2.438.8) directed against the QM Ab (17.2.25 monoclonal) was a gift from Dr. Imanishi-Kari (Tufts University, Boston, MA). All other Abs were purchased from BD Pharmingen. FITCconjugated mAbs were anti-mouse CD21 (7G6), IgDa (AMS9.1), GL7 and B220 (RA3-6B2). PE-conjugated mAbs were anti-mouse CD23 (B3B4), IgMa (DS-1), CD138 (281-2) and FAS (CD95). Biotinylated mAbs were anti-mouse IgDa (AMS9.1) and CD138 (281-2). Allophycocyanin-conjugated mAbs were anti-mouse CD19 (ID3) and B220 (RA3-6B2). Peanut agglutinin was biotinylated (Vector Laboratories). Biotinylated Abs were revealed by streptavidin-PE-Cy5 purchased from BD Pharmingen. Data were collected using FACScan or FACSCalibur and analyzed with CellQuest software. For the annexin V binding assay, the cells were first stained with Abs directed to surface Ags and later stained with the AnnexinV-PE Apoptosis Detection kit 1 (BD Pharmingen) according to the manufacturer's recommended protocol. Cell cycle analysis was done according to previously described procedures (20) in isolated B cells.
Results
TACI deficiency compromises IgG TI-2 Ab production and formation of ASCs in QM mice
To explore the involvement of TACI in TI-2 Ab responses, we bred TACI-KO mice (TACI ) B cells (Fig. 1b) . QM mice respond vigorously to NP-Ficoll, a TI-2 stimulus, by producing NP-specific IgM (3246 g/ml) and IgG3 (9.0 g/ml) in the serum 4 days after immunization. QM mice deficient in TACI produced only 1.6 g/ml NP-specific serum IgG3, 5.6-fold less than TACI ϩ QM littermates and comparable levels of NP-specific serum IgM (2673 g/ml), indicating that TACI promotes IgG3 production in response to TI-2 stimuli in QM mice.
Next, we asked whether TACI was required to produce QM ASCs in the spleen after immunization with NP-Ficoll. The number of NP-specific ASCs was determined by ELISPOT 6 days after immunization. TACI Ϫ QM mice showed 2-fold decreased numbers of IgM and 1.6-fold-decreased numbers of IgG NP-specific ASCs per spleen, compared with TACI ϩ QM mice (Fig. 2a) . The number of IgM or IgG ASCs in the bone marrow was also decreased albeit not significantly, by 1.8-and 1.2-fold, respectively, in TACI Ϫ mice compared with TACI ϩ QM mice. Analysis of spleen sections showed that the number of B cells that differentiated into plasma cells (CD138 ϩ ) peaked at day 6 and slowly decreased thereafter (not shown). The number of plasma cells in the perifollicular areas of the spleen was significantly decreased in TACI Ϫ compared with TACI ϩ QM mice 6 days after immunization (Fig. 2b) . Given that the precursor frequencies of NP-specific B cells were the same in TACI Ϫ QM and TACI ϩ QM mice (ϳ85% for both; data not shown), our findings of reduced splenic ASC in QM mice deficient in TACI indicate that TACI promotes terminal differentiation. Decreased numbers of plasma cells were not due to increased apoptosis in TACI Ϫ QM mice, because TACI Ϫ CD138 ϩ cells had reduced apoptosis (Fig. 3, d and f) , a finding consistent with published reports indicating that an EDAR-TACI fusion induces death in the A20 mouse plasma cell line (17) .
TACI deficiency causes B cells to remain proliferating longer and to differentiate less after TI-2 Ag stimulation in vivo
We next tested whether TACI promotes B cell differentiation early or late relative to B cell activation. We first determined whether TACI deficiency enhances QM B cell proliferation by calculating the relative number of CD19 ϩ cells in the G 2 -S and M stages of the cell cycle after immunization. Fig. 3a shows that 6 days after immunization there were more TACI Ϫ QM B cells cycling (in G 2 -S or M stages of the cell cycle, 9.6% on average), compared with TACI ϩ B cells (5.9% on average). Curiously, the number of TACI ϩ and TACI Ϫ B cells cycling 4 days after immunization is similar, suggesting that TACI is necessary at a time remote from activation, thus limiting clonal expansion. Fig. 3a also shows that the number of cycling B cells was greater in nonimmunized mice (2-fold in TACI ϩ mice and 1.6-fold in TACI Ϫ mice) than day at 6 postimmunization. We speculate that the cycling B cells in the nonimmunized mice are highly selected QM idiotype (Id) Ϫ B cells (19) responding to a variety of environmental Ags producing diverse Ig. In contrast, after immunization with NP-Ficoll Id ϩ B cells are synchronously stimulated and produce homogeneous Ig, which will give rise to immune complexes that inhibit Id ϩ B cell activation, decreasing the number of cycling B cells 6 days after immunization.
To determine the extent to which TACI decreases B cell blasts after immunization, we analyzed spleen sections and splenocytes obtained from TACI Ϫ or TACI ϩ QM mice by flow cytometry at days 4 and 6 after immunization. Mouse B cell blasts express an epitope recognized by a rat mAb, GL7. GL7 binds to sialylated glycans, the ␣-2,6-linked N-acetylneuraminic acid (Neu5Ac) on lactosamine glycan chains. Neu5Ac expression increases in germinal center B cells owing to repression of CMP-Neu5Ac hydroxylase which converts Neu5Ac to N-glycolylneuraminic acid that is not recognized by GL7. Naito et al. (21) showed recently that N-glycolylneuraminic acid represses B cell activation and therefore specific suppression of CMP-Neu5Ac hydroxylase enhances activation of germinal center B cells. T-independent stimulation of QM mice generates short-lived germinal centers that mark extensive B cell proliferation (22, 23) . The number and size of GL7 ϩ clusters were increased in TACI Ϫ mice 6 days after immunization (Fig. 3b) . The proportion of follicles with GL7 ϩ germinal centers was 88% in TACI Ϫ mice and only 51% in TACI ϩ mice 6 days after immunization, indicating enhanced late B cell proliferation in TACI Ϫ QM mice (Fig. 3b) . Consistently, the number and proportion of B cells (B220-positive) that are blasts (GL7 ϩ ) were reproducibly increased in the absence of TACI after immunization (Fig.  3, c and d) . More than 80% of the GL7 ϩ B cells also expressed other germinal center markers such as Fas, bound the peanut agglutinin lectin, and were IgD Ϫ . These results suggest that TACI is necessary to stop cycling to allow terminal differentiation.
TACI deficiency caused impaired plasma cell differentiation owing to a B cell autonomous defect
To determine whether the impaired Ab production in response to NPFicoll was owed to deficiency of TACI on B cells, we performed adoptive transfer experiments. Ten million QM B cells (CD19 ϩ ) that have or lack TACI were transferred into RAG1 Ϫ/Ϫ recipients (n ϭ 5). At day 6 postimmunization, spleens from recipient mice had 16 (Ϯ3.9) ϫ 10 6 or 16 (Ϯ8.9) ϫ 10 6 QM TACI ϩ or QM TACI Ϫ B cells on average, respectively. Recipients of QM TACI ϩ B cells produced 2,789 IgM and 999 IgG NP-specific ASCs per 200,000 splenocytes, whereas recipients of QM TACI Ϫ cells produced only 1,561 IgM and 187 IgG NP-specific ASCs per 200,000 splenocytes (Fig. 4) . The number of NP-specific ASCs in the bone marrow was Ͼ10-fold reduced compared with the number in the spleen and did not differ in mice reconstituted with QM TACI ϩ or with QM TACI Ϫ B cells (Fig.  4) . These results indicate that expression of TACI by B cells suffices to enhance Ab production in response to TI-2 stimuli. (Fig. 5a ), indicating that TACI is not required for activation of B cells. TACI Ϫ splenocytes proliferated more than TACI ϩ splenocytes in response to LPS but not to NP-Ficoll (Fig. 5, b and c, respectively) . However, isolated TACI Ϫ or TACI ϩ B cells proliferated equally in response to LPS (Fig. 5b) . Because LPS but not NP-Ficoll stimulates macrophages/monocytes and dendritic cells to produce TACI ligands (24) , TACI inhibition of proliferation is apparent only in splenocyte cultures responding to LPS. It is possible that upon LPS stimulation macrophages/monocytes and dendritic cells express glycosaminoglycans that bind APRIL (25) , enhancing its stimulatory function.
The inhibitory properties of TACI do not account for the notably decreased Ab responses to TI-2 stimuli. To determine whether TACI promoted plasma cell differentiation, we analyzed expression of syndecan-1 (CD138, a marker of plasma cells) by TACI ϩ or by TACI Ϫ QM B cells by flow cytometry, 72 h after stimulation. Fig. 5d shows that the number of putative plasma cells (CD138 ϩhigh ) was 2-fold lower in cells lacking TACI than in TACI ϩ cells. These results confirmed that TACI is required for efficient plasma cell differentiation.
Discussion
Here we show that TACI expressed by B cells has a dual function. In support of this conclusion, we found that although Ag-stimulated B cells lacking TACI were normally activated in response to Ag, they proliferated longer and differentiated poorly into ASCs both in vivo and in vitro. Thus, we conclude that a defect in plasma cell differentiation is the cause for the deficient TI-2 Ab production in TACI-KO mice. TACI Ϫ QM mice produced normal levels of NP-specific IgM in response to NP-Ficoll despite severely reduced IgM ASCs. These results suggest that in QM TACI Ϫ mice, serum IgM is not produced by terminally differentiated B cells (detected in ELISPOT). In fact, Abs can be made by B cells before terminal differentiation in relatively small amounts on a per cell basis (26) . Thus, initial IgM Ab production depends greatly on the clonal size. Because we show that TACI Ϫ QM B cells proliferate to a greater extent and longer than TACI ϩ QM B cells, the clonal size must be larger in the absence of TACI. Therefore, the relatively normal early IgM responses by QM TACI Ϫ mice may be attributed to Ig secretion by nonplasma cells. Because IgG-producing cells arise later, switched cells are a minority in the clone, and thus the IgG serum level is mostly the product of plasma cells. As TACI promotes differentiation into plasma cells, IgG plasma cells are decreased in TACI Ϫ relative to TACI ϩ mice, explaining the severely reduced IgG serum levels. It is possible that accelerated proliferation of TACI-KO B cells, in fact, contributes to their decreased ability to differentiate, as is thought to occur in B cells of p18 KO mice (27) .
Our results explain how human subjects with common variable immunodeficiency owing to mutations of TACI have specific defects in the production of switched Ig isotypes with an intact classswitching mechanism (28, 29) . In these patients, a larger initial clonal size composed mainly of undifferentiated IgM ϩ B cells would account for the relatively normal IgM levels. In contrast to IgM-producing cells, B cells secreting switched isotypes are much less frequent, and therefore the serum level of switched isotypes is mostly owed to differentiated plasma cells. Thus, excessive expansion and impaired differentiation of B cells in TACI-defective subjects results in switched Ig isotype defects (28, 29) .
T-independent activation of B cells induces activation induced cytidine deaminase expression (30) , somatic hypermutation (23) , and germinal center formation (22) , and therefore may potentially originate autoreactive Abs. How the generation of autoreactive Abs is prevented following T-independent stimuli is not known. Assuming that activation induced cytidine deaminase is expressed and the rate of mutation is maintained during clonal expansion, mutants will accumulate in an exponential manner (31) . Thus, increased clonal sizes owing to TACI deficiency may increase substantially the number of B cells producing mutated and autoreactive Abs in response to T-independent stimulation. Thus, TACI may limit the development of autoreactive Abs by decreasing clonal expansion and because plasma cells do not mutate, by promoting rapid differentiation. Our results indicate that engagement of TACI promotes termination of proliferation and plasma cell differentiation, limiting the chances of forming autoreactive Abs following T-independent stimulation. This possibility is in agreement with the findings of Grewal and collaborators, who showed increased incidence of autoimmune Abs in aged TACI-KO mice (17) .
